Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.
Silva RLE, Kanan Y, Mirando AC, Kim J, Shmueli RB, Lorenc VE, Fortmann SD, Sciamanna J, Pandey NB, Green JJ, Popel AS, Campochiaro PA.
Silva RLE, et al. Among authors: mirando ac.
Sci Transl Med. 2017 Jan 18;9(373):eaai8030. doi: 10.1126/scitranslmed.aai8030.
Sci Transl Med. 2017.
PMID: 28100839
Free PMC article.